| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |